Ault Milton C III

DirectorAlzamend Neuro, Inc. (ALZN) · full profile →Form 4 · filed Oct 3, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$297K
Net Open-Market Flow
-$297K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 3, 2025Sell(S)66K$2.44$161K8K
Oct 2, 2025Sell(S)21K$2.39$49K74K
Oct 1, 2025Sell(S)37K$2.35$86K95K
Oct 1, 2025Conversion(C)100K$2.32$232K132K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 1, 2025Conversion(C)232$1000.00$232K607

Transaction Codes

S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001214659-25-014629) within minutes of acceptance. Every field above traces to the original document. Verify it directly: